{"id":"W4380203508","doi":"10.51731/cjht.2023.667","title":"Axicabtagene Ciloleucel (Yescarta)","year":2023,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"","keywords":"Chemoimmunotherapy; Reimbursement; Medicine; Lymphoma; Drug; Refractory (planetary science); Oncology; Intensive care medicine; Internal medicine; Pharmacology; Health care; Rituximab; Political science","routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004575623,0.0002454125,0.0002658014,0.0007423108,0.0002513322,0.0007425893,0.0004443643,0.0006175428,0.02877796],"category_scores_gemma":[0.0006955131,0.00008204261,0.0003862987,0.0004545841,0.0003228043,0.0003923416,0.0002866676,0.000595799,0.004697503],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001557321,"about_ca_system_score_gemma":0.002465878,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.01720674,"about_ca_topic_score_gemma":0.07261575,"domain_scores_codex":[0.9997481,0.00004207664,0.00002093312,0.00003195338,0.000123262,0.00003365567],"domain_scores_gemma":[0.9997236,0.00005526808,0.0000603757,0.000009357965,0.00009760946,0.00005376762],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.001211255,0.0001365379,0.000973531,0.003716572,0.00009383831,0.0002392418,0.00003417788,0.0001580746,0.0107855,0.004084606,0.1616195,0.8169472],"study_design_scores_gemma":[0.0006023819,0.001144094,0.004467091,0.000878264,0.0001119561,0.000625764,0.00004101624,0.0001707624,0.006011587,0.0003468022,0.9855834,0.00001696065],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"other","genre_scores_codex":[0.02543784,0.6080985,0.002322317,0.01387976,0.002517675,0.0007423409,0.006308315,0.000714529,0.3399788],"genre_scores_gemma":[0.2376078,0.4042802,0.008284527,0.01984626,0.001199402,0.0007027326,0.01056201,0.0001626756,0.3173545],"genre_candidate":"other","genre_consensus":null,"teacher_disagreement_score":0.02877796,"threshold_uncertainty_score":0.09627187,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.07583853752595779,"score_gpt":0.3578749622160254,"score_spread":0.2820364246900676,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}